Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

[Cytomegalovirus myositis complicated with hemophagocytic lymphohistiocytosis, acute renal failure, and colitis].

Matsuo K, Nishihara H, Koga M, Omoto M, Ogasawara J, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2018 Jun 30. doi: 10.5692/clinicalneurol.cn-001119. [Epub ahead of print] Japanese.

PMID:
29962438
2.

Electrical Stimulation of the Antagonist Muscle during Cycling Exercise Interval Training Improves Oxygen Uptake and Muscle Strength.

Hashida R, Takano Y, Matsuse H, Kudo M, Bekki M, Omoto M, Nago T, Kawaguchi T, Torimura T, Shiba N.

J Strength Cond Res. 2017 Dec 20. doi: 10.1519/JSC.0000000000002393. [Epub ahead of print]

PMID:
29278576
3.

Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.

Nawata T, Kubo M, Mitsui H, Oishi K, Omoto M, Kanda T, Yano M.

Intern Med. 2018 Mar 15;57(6):883-886. doi: 10.2169/internalmedicine.9307-17. Epub 2017 Nov 20.

4.

Biosimilars: State of Clinical and Regulatory Science.

Klein AV, Wang J, Feagan BG, Omoto M.

J Pharm Pharm Sci. 2017;20(1):332-348. doi: 10.18433/J3VK90.

5.

Simulation of oxygen uptake and leg joint reaction force during ergometer exercise under altered gravity.

Tagawa Y, Yamamoto N, Omoto M, Matsuse H, Shiba N.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1901-1904. doi: 10.1109/EMBC.2017.8037219.

PMID:
29060263
6.

Steroid-responsive demyelinating peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells.

Sano H, Maeda T, Omoto M, Ogasawara JI, Koga M, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2017 Oct 27;57(10):573-578. doi: 10.5692/clinicalneurol.cn-001064. Epub 2017 Sep 28. Japanese.

PMID:
28954972
7.

Charcot-Marie-Tooth disease type 2 caused by homozygous MME gene mutation superimposed by chronic inflammatory demyelinating polyneuropathy.

Fujisawa M, Sano Y, Omoto M, Ogasawara JI, Koga M, Takashima H, Kanda T.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):515-520. doi: 10.5692/clinicalneurol.cn-001036. Epub 2017 Aug 31. Japanese.

PMID:
28855494
8.

Autopsy case of the C12orf65 mutation in a patient with signs of mitochondrial dysfunction.

Nishihara H, Omoto M, Takao M, Higuchi Y, Koga M, Kawai M, Kawano H, Ikeda E, Takashima H, Kanda T.

Neurol Genet. 2017 Jul 27;3(4):e171. doi: 10.1212/NXG.0000000000000171. eCollection 2017 Aug.

9.

IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity.

Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R.

J Immunol. 2017 Aug 1;199(3):1163-1169. doi: 10.4049/jimmunol.1602144. Epub 2017 Jun 21.

PMID:
28637904
10.

Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Omoto M, Suri K, Amouzegar A, Li M, Katikireddy KR, Mittal SK, Chauhan SK.

Mol Ther. 2017 Aug 2;25(8):1881-1888. doi: 10.1016/j.ymthe.2017.04.020. Epub 2017 May 11.

PMID:
28502469
11.

Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation.

Tahvildari M, Emami-Naeini P, Omoto M, Mashaghi A, Chauhan SK, Dana R.

Sci Rep. 2017 Apr 20;7(1):971. doi: 10.1038/s41598-017-01065-z.

12.

Establishment of a new conditionally immortalized human skeletal muscle microvascular endothelial cell line.

Sano H, Sano Y, Ishiguchi E, Shimizu F, Omoto M, Maeda T, Nishihara H, Takeshita Y, Takahashi S, Oishi M, Kanda T.

J Cell Physiol. 2017 Dec;232(12):3286-3295. doi: 10.1002/jcp.25772. Epub 2017 Apr 18.

PMID:
28063233
13.

Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome.

Nawata T, Kubo M, Okuda S, Omoto M, Yujiri T, Kanda T, Yano M.

Scand J Rheumatol. 2017 Nov;46(6):496-498. doi: 10.1080/03009742.2016.1253770. Epub 2016 Dec 9. No abstract available.

PMID:
27931156
14.

Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.

Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, Takano Y, Ueno T, Koga H, George J, Shiba N, Torimura T.

J Hepatol. 2017 Jan;66(1):142-152. doi: 10.1016/j.jhep.2016.08.023. Epub 2016 Sep 14. Review.

PMID:
27639843
15.

Restoration of Corneal Transparency by Mesenchymal Stem Cells.

Mittal SK, Omoto M, Amouzegar A, Sahu A, Rezazadeh A, Katikireddy KR, Shah DI, Sahu SK, Chauhan SK.

Stem Cell Reports. 2016 Oct 11;7(4):583-590. doi: 10.1016/j.stemcr.2016.09.001. Epub 2016 Sep 29.

16.

A New Training for Older Adults Using Combined Neuromuscular Electrical Stimulation and Volitional Contraction: A Pilot Study.

Takano Y, Matsuse H, Tsukada Y, Omoto M, Hashida R, Shiba N.

Kurume Med J. 2016;62(3-4):73-81. doi: 10.2739/kurumemedj.MS66001. Epub 2016 May 25.

17.

Walking Exercise Simultaneously Combined With Neuromuscular Electrical Stimulation of Antagonists Resistance Improved Muscle Strength, Physical Function, and Knee Pain in Symptomatic Knee Osteoarthritis: A Single-Arm Study.

Matsuse H, Hashida R, Takano Y, Omoto M, Nago T, Bekki M, Shiba N.

J Strength Cond Res. 2017 Jan;31(1):171-180. doi: 10.1519/JSC.0000000000001463.

PMID:
27135477
18.

Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye.

Črnej A, Omoto M, Dohlman TH, Gonzalez-Andrades M, Paschalis EI, Cruzat A, Vu TH, Doorenbos M, Chen DF, Dohlman CH, Dana R.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1643-8. doi: 10.1167/iovs.15-17557.

19.

E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation.

Dohlman TH, Di Zazzo A, Omoto M, Hua J, Ding J, Hamrah P, Chauhan SK, Dana R.

Transplantation. 2016 Apr;100(4):772-80. doi: 10.1097/TP.0000000000001107.

20.

In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.

Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R.

Transplantation. 2016 Mar;100(3):525-32. doi: 10.1097/TP.0000000000001044.

21.

[Systemic vasculitic neuropathy diagnosed by means of (18)F-FDG PET CT].

Fujikawa S, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2016;56(2):88-92. doi: 10.5692/clinicalneurol.cn-000803. Epub 2016 Jan 21. Japanese.

PMID:
26797481
22.

Cycling Exercise with Electrical Stimulation of Antagonist Muscles Increases Plasma Growth Hormone and IL-6.

Omoto M, Matsuse H, Hashida R, Takano Y, Yamada S, Ohshima H, Tagawa Y, Shiba N.

Tohoku J Exp Med. 2015 Nov;237(3):209-17. doi: 10.1620/tjem.237.209.

23.

Correction: Electrically Stimulated Antagonist Muscle Contraction Increased Muscle Mass and Bone Mineral Density of One Astronaut--Initial Verification on the International Space Station.

Shiba N, Matsuse H, Takano Y, Yoshimitsu K, Omoto M, Hashida R, Tagawa Y, Inada T, Yamada S, Ohshima H.

PLoS One. 2015 Sep 14;10(9):e0138519. doi: 10.1371/journal.pone.0138519. eCollection 2015. No abstract available.

24.

Electrically Stimulated Antagonist Muscle Contraction Increased Muscle Mass and Bone Mineral Density of One Astronaut - Initial Verification on the International Space Station.

Shiba N, Matsuse H, Takano Y, Yoshimitsu K, Omoto M, Hashida R, Tagawa Y, Inada T, Yamada S, Ohshima H.

PLoS One. 2015 Aug 21;10(8):e0134736. doi: 10.1371/journal.pone.0134736. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138519.

25.

[A case of chronic progressive motor-dominant multiple mononeuritis associated with primary Sjögren's syndrome].

Saitoh BY, Hayashi S, Kamada T, Murai H, Omoto M, Kira J.

Rinsho Shinkeigaku. 2015;55(10):753-8. doi: 10.5692/clinicalneurol.cn-000748. Epub 2015 Aug 18. Japanese.

PMID:
26289762
26.

Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.

Sugaya S, Chen WS, Cao Z, Kenyon KR, Yamaguchi T, Omoto M, Hamrah P, Panjwani N.

Cornea. 2015 Jun;34(6):675-681. doi: 10.1097/ICO.0000000000000439.

27.

Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.

Sano Y, Nakano Y, Omoto M, Takao M, Ikeda E, Oga A, Nakamichi K, Saijo M, Maoka T, Sano H, Kawai M, Kanda T.

Intern Med. 2015;54(8):965-70. doi: 10.2169/internalmedicine.54.2308. Epub 2015 Apr 15.

28.

VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.

Dohlman TH, Omoto M, Hua J, Stevenson W, Lee SM, Chauhan SK, Dana R.

Transplantation. 2015 Apr;99(4):678-86. doi: 10.1097/TP.0000000000000512.

PMID:
25606789
29.

Corneal inflammation after miniature keratoprosthesis implantation.

Crnej A, Omoto M, Dohlman TH, Dohlman CH, Dana R.

Invest Ophthalmol Vis Sci. 2014 Dec 16;56(1):185-9. doi: 10.1167/iovs.14-15884.

30.

Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.

Yamazoe K, Yamazoe K, Yamaguchi T, Omoto M, Shimazaki J.

Cornea. 2014 Nov;33(11):1157-63. doi: 10.1097/ICO.0000000000000258.

PMID:
25255133
31.

Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.

Omoto M, Katikireddy KR, Rezazadeh A, Dohlman TH, Chauhan SK.

Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6631-8. doi: 10.1167/iovs.14-15413.

PMID:
25228546
32.

Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.

Emami-Naeini P, Dohlman TH, Omoto M, Hattori T, Chen Y, Lee HS, Chauhan SK, Dana R.

Graefes Arch Clin Exp Ophthalmol. 2014 Nov;252(11):1755-62. doi: 10.1007/s00417-014-2749-5. Epub 2014 Aug 5.

33.

A novel murine model for keratoprosthesis.

Crnej A, Omoto M, Dohlman TH, Graney JM, Dohlman CH, Drnovsek-Olup B, Dana R.

Invest Ophthalmol Vis Sci. 2014 May 15;55(6):3681-5. doi: 10.1167/iovs.14-14058.

34.

[Leptomeningeal gliomatosis with high levels of adenosine deaminase in the cerebrospinal fluid].

Nishihara H, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2014;54(4):308-12. Japanese.

PMID:
24807273
35.

Keratoplasty postoperative treatment update.

Shimmura-Tomita M, Shimmura S, Satake Y, Shimazaki-Den S, Omoto M, Tsubota K, Shimazaki J.

Cornea. 2013 Nov;32 Suppl 1:S60-4. doi: 10.1097/ICO.0b013e3182a2c937.

PMID:
24104936
36.

Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.

Shimizu F, Omoto M, Sano Y, Mastui N, Miyashiro A, Tasaki A, Maeda T, Koga M, Kaji R, Kanda T.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):526-37. doi: 10.1136/jnnp-2013-305405. Epub 2013 Aug 7.

PMID:
23926278
37.

NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.

Haruki H, Sano Y, Shimizu F, Omoto M, Tasaki A, Oishi M, Koga M, Saito K, Takahashi T, Nakada T, Kanda T.

J Neurol Sci. 2013 Aug 15;331(1-2):136-44. doi: 10.1016/j.jns.2013.05.035. Epub 2013 Jun 25.

PMID:
23809190
38.

The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.

Dohlman TH, Chauhan SK, Kodati S, Hua J, Chen Y, Omoto M, Sadrai Z, Dana R.

Invest Ophthalmol Vis Sci. 2013 Jun 12;54(6):4081-91. doi: 10.1167/iovs.12-11216.

39.

The semaphorin 3A inhibitor SM-345431 accelerates peripheral nerve regeneration and sensitivity in a murine corneal transplantation model.

Omoto M, Yoshida S, Miyashita H, Kawakita T, Yoshida K, Kishino A, Kimura T, Shibata S, Tsubota K, Okano H, Shimmura S.

PLoS One. 2012;7(11):e47716. doi: 10.1371/journal.pone.0047716. Epub 2012 Nov 9.

40.

Neuropathy in chronic graft-versus-host disease caused by donor T cells.

Haruki H, Koga M, Ogasawara J, Omoto M, Kawai M, Kanda T.

Muscle Nerve. 2012 Oct;46(4):610-1. doi: 10.1002/mus.23524. No abstract available.

PMID:
22987708
41.

Kinetics and function of mesenchymal stem cells in corneal injury.

Lan Y, Kodati S, Lee HS, Omoto M, Jin Y, Chauhan SK.

Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3638-44. doi: 10.1167/iovs.11-9311.

PMID:
22562508
42.

Autosomal dominant tauopathy with parkinsonism and central hypoventilation.

Omoto M, Suzuki S, Ikeuchi T, Ishihara T, Kobayashi T, Tsuboi Y, Ogasawara J, Koga M, Kawai M, Iwaki T, Kanda T.

Neurology. 2012 Mar 6;78(10):762-4. doi: 10.1212/WNL.0b013e318248e531. Epub 2012 Feb 22. No abstract available.

PMID:
22357714
43.

p.Arg332Cys mutation of NOTCH3 gene in two unrelated Japanese families with CADASIL.

Sano Y, Shimizu F, Kawai M, Omoto M, Negoro K, Kurokawa T, Fujisawa H, Suzuki M, Okayama N, Suehiro Y, Hinoda Y, Kanda T.

Intern Med. 2011;50(22):2833-8. Epub 2011 Nov 15.

44.

[Good response to intravenous immunoglobulin therapy in sensory dominant distal variant of chronic inflammatory demyelinating polyneuropathy].

Takeshita Y, Koga M, Omoto M, Ogasawara J, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2011 Jul;51(7):478-82. Japanese.

PMID:
21823506
45.

[A case of POEMS syndrome with enlarged pancreas due to IgG4-related autoimmune pancreatitis].

Nishihara H, Ogasawara J, Koga M, Omoto M, Kawai M, Kanda T.

Rinsho Shinkeigaku. 2011 Jun;51(6):417-21. Japanese.

PMID:
21735734
46.

Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.

Shimazaki J, Den S, Omoto M, Satake Y, Shimmura S, Tsubota K.

Am J Ophthalmol. 2011 Jul;152(1):33-39.e1. doi: 10.1016/j.ajo.2011.01.019. Epub 2011 May 12.

PMID:
21570054
47.

Simultaneous deep anterior lamellar keratoplasty and limbal allograft in bilateral limbal stem cell deficiency.

Omoto M, Shimmura S, Hatou S, Ichihashi Y, Kawakita T, Tsubota K.

Jpn J Ophthalmol. 2010 Nov;54(6):537-43. doi: 10.1007/s10384-010-0879-9. Epub 2010 Dec 30.

PMID:
21191713
48.

Subepithelial corneal fibrosis partially due to epithelial-mesenchymal transition of ocular surface epithelium.

Kawashima M, Kawakita T, Higa K, Satake Y, Omoto M, Tsubota K, Shimmura S, Shimazaki J.

Mol Vis. 2010 Dec 15;16:2727-32.

49.

Retinal phototoxicity in a novel murine model of intraocular lens implantation.

Kurihara T, Omoto M, Noda K, Ebinuma M, Kubota S, Koizumi H, Yoshida S, Ozawa Y, Shimmura S, Ishida S, Tsubota K.

Mol Vis. 2009 Dec 12;15:2751-61.

Supplemental Content

Support Center